Search results

While certain contested goods do manage to make their way to market, others have moved less far in this direction and others seem permanently unable to do so. Moral contestation promotes, holds back or blocks the emergence of contested markets. This chapter examines the conditions that make the operation of these markets possible, and those that block their appearance. From a comparison between two cases (organs for transplantation and gambling), the authors focus attention on the one hand on those devices that make transactions possible, and on the other, on the “vulnerable populations” that these devices are intended to protect, either from or by the market.

This chapter provides a comprehensive review of several social-cognitive models that have been lately applied in public health and donation contexts. The current review included the elaboration likelihood model (ELM), the prototype willingness model (PWM), and the organ donation model (ODM). This review also details and discusses the main strengths and limitations of these models. Importantly, this review helps to identify the gap of the current social marketing and health-care literature. In particular, this chapter provides a solid theoretical foundation and has initiated further pathways for future researchers who are interested in the fields of public health and social change literature, organ donation context, as well as social-cognitive decision-making models. The significance of this review is defined by advancing public health practitioners, social marketing communicators, and educationalists, evidencing how conceptual models can inform and guide the research.

This chapter addresses the alienability or inalienability of the bodily self by looking at continuing legal, economic, and cultural issues surrounding three case studies: the growth of cell lines, live organ transfer, and the practices of “forced prostitution” as a contemporary form of slavery. The essay contends that it is, ironically, Locke and Hegel's shared hyperliberal notion of the self as inalienable property that sustains a potential basis, in law and in culture, for troubling cases of self-alienation which persist in the case studies offered.

Purpose – To examine the introduction of a practice known as Donation after Cardiac Death (DCD) into Australian hospitals notwithstanding that DCD constitutes a significant shift in medical practice. The shift is from holding off organ donation activities until after death has occurred (the Brain Death Scenario and Uncontrolled Cardiac Death Scenario) to progressing the injured patient to organ donor on the basis of an early prognostic call. The more precise term is ‘Controlled DCD’. What is controlled are the timing, location, mode and criteria of death.Findings – Controlled DCD first appears as an ‘inpatient trial’ in Pittsburgh, United States, in 1992, and has progressed, via various organisations and committees, to being used in a number of countries, including Australia and New Zealand, and being embodied in national, state and hospital protocols. Along the way, concerns that previously precluded such activity have been consistently raised and documented. Operational accounts reported in the medical literature do not acknowledge this history or the ethically problematic aspects of the practice. It is likely that these operational reports and related information sources, together with promotion of the positives of organ donation, have facilitated the practice’s progress through the relevant institutional committees.Social implications – Much is at stake when the quest for more organ donors starts changing what can be done to patients. How this practice has come to be tolerated in 2012, despite a number of irresolvable ethical issues, is a matter of vital community interest.Originality/value of chapter – This chapter is part of an ongoing study by the authors.

Much progress has been made in public opinion regarding drug prohibition. The policy has been an utter failure, very expensive, and increasingly disliked by people around the world. As a result, several states have passed drug reform legislation that reduces penalties for the production, distribution, and consumption of previously prohibited substances such as narcotics and marijuana. Other states have placed more resources in drug treatment programs (demand reduction) instead of drug interdiction efforts (supply reduction). In North America, several states in the US and Canada have passed medical marijuana legislation to take advantage of the well-known medical benefits of marijuana (Piper, Matthew, Katherine, & Rebecca, 2003).

This chapter aims to reflect upon the relationship between corporate social responsibility (CSR) and human rights. We argue that although CSR is a good attempt to propose better practices for managerial decisions, a human rights perspective enriches this vision. Therefore, the authors will define the meaning of a human rights perspective for business activities and, specifically, for CSR. The authors apply the idea of res extra commercium to human rights and CSR. As a first step, both factors need to be identified as moral absolutes. Essentially, businesses should start by identifying areas of human activity that are off limits.

In this chapter I consider the need for consent in two cases of posthumous donation of parts of one’s body: organ donation and the donation of sperm to allow one’s partner to conceive a child after one’s death. What kind of consent is appropriate in these cases and why? In both cases, jurisdictions tend to prefer explicit consent, although many countries now adopt presumed consent (opt-out) in the case of organ donation, and there has been a recent plea for presumed consent in the case of sperm donation as well. In this chapter I first argue that arguments in favour of presumed consent are inadequate as they stand, and then describe another way of understanding opt-out schemes, one that focuses on different models of what is at stake and on the ethical requirements incurred on such models.